Amphastar Pharmaceuticals, Inc. Financial Ratios — AMPH

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	15.5	4.89	-4.01	-0.97	3.14	1.1	-1.72	13.71	0.36	14.65	18.76	23.55	23.26	12.9
Return on Assets (%)	- -	11.4	3.62	-2.94	-0.72	2.4	0.83	-1.19	8.89	0.23	9.54	12.93	12.2	10.32	6.12
Return on Capital (%)	- -	13.74	4.51	- -	- -	2.99	- -	- -	11.33	0.36	11.56	15.72	16.86	13.99	8.37
Return on Invested Capital (%)	- -	14.01	4.32	- -	- -	2.89	- -	- -	-0.01	0.51	9.83	14.41	16.93	13.07	7.87
Gross Margin (%)	23.75	44.2	37.86	24.35	30.75	40.83	37.68	36.31	40.92	40.97	45.63	49.87	54.49	51.08	49.46
EBITDA Margin (%)	-18.87	19.08	13.36	-1.68	2.53	11.78	4.95	2.68	6.54	10.33	22.03	27.21	37.05	35.88	28.28
Operating Margin (%)	-28.29	13.45	7.67	-8.54	-2.74	6.03	-1.63	-2.93	-0.01	3.13	15.96	21.54	30.57	28.06	19.5
Incremental Operating Margin (%)	- -	70.92	-38.94	- -	- -	610.92	- -	- -	- -	39.99	67.03	61.44	61.54	9.63	538.21
Pretax Margin (%)	-26.94	12.67	7.5	-8.62	-4.12	5.73	0.52	-3.37	18.68	1.33	19.22	23.26	26.59	25.93	17.17
Profit Margin (%)	6.55	8.86	5.16	-5.08	-1.11	3.85	1.52	-1.95	15.18	0.4	14.19	18.31	21.34	21.79	13.63
Net Income to Common Margin (%)	6.55	8.86	5.16	-5.08	-1.11	3.85	1.52	-1.95	15.18	0.4	14.19	18.31	21.34	21.79	13.63
Effective Tax Rate (%)	- -	30.08	31.14	- -	- -	32.88	- -	- -	22.79	76.34	24.52	20.23	18.58	15.64	20.65
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	15.5	4.89	-4.01	-0.97	3.14	1.1	-1.72	13.71	0.36	14.65	18.76	23.55	23.26	12.9

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	38	32	44	41	38	47	50	67	67	105	103	624	651	656
ST Debt	- -	22	22	8	11	5	6	18	11	16	5	6	4	7	10
LT Debt	- -	16	10	36	30	32	41	32	56	52	99	97	619	644	646
Total Debt/EBITDA	- -	0.97	1.05	-12.36	6.47	1.26	3.96	6.36	3.16	1.86	1.09	0.76	2.61	2.48	3.22
Net Debt/EBITDA	- -	-0.31	-0.7	6.83	-3.93	-1.15	-1.55	-4.58	-1.26	-1.28	-0.51	-0.59	1.87	1.71	2.16
Total Debt/EBIT	- -	1.38	1.83	-2.43	-5.96	2.45	-12.05	-5.82	-1,708.33	6.14	1.5	0.95	3.17	3.17	4.67
Net Debt/EBIT	- -	-0.44	-1.22	1.34	3.62	-2.25	4.71	4.19	680.77	-4.22	-0.71	-0.75	2.26	2.19	3.14
EBITDA to Interest Expense	-38.23	49.73	32.04	-5.8	6.44	29.35	14.4	32.48	177.16	96.61	108.95	73.55	8.79	8.66	7.99
EBITDA-CapEx/Interest Expense	-55.31	18.3	13.62	-39.46	-9.77	8.47	-28.09	-160.14	-172.04	6.09	77.93	60.53	7.39	7.3	6.53
EBIT to Interest Expense	-57.33	35.07	18.39	-29.53	-6.99	15.02	-4.74	-35.49	-0.33	29.29	78.97	58.23	7.25	6.77	5.51
Interest Expense	1	1	1	1	1	1	1	- -	- -	- -	1	2	27	30	25
Common Equity/Total Assets	- -	73.53	74.26	72.39	75.75	76.98	73.99	64.73	64.97	63.73	66.34	71.25	42.26	46.42	48.41
Long-Term Debt/Equity (%)	- -	6.83	4	12.81	10.21	9.83	12.24	8.78	13.03	11.51	22.33	18.26	96.85	87.88	81.95
Long-Term Debt/Capital (%)	- -	5.88	3.55	11.09	8.96	8.82	10.72	7.71	11.27	10.01	18.08	15.29	49.03	46.54	44.74
Long-Term Debt/Total Assets (%)	- -	5.02	2.97	9.27	7.73	7.56	9.05	6.23	9.49	8.18	14.81	13.01	40.93	40.79	39.68
Total Debt/Equity (%)	- -	16.28	12.79	15.5	13.91	11.46	14.13	13.78	15.58	14.99	23.49	19.4	97.53	88.84	83.16
Total Debt/Capital (%)	- -	14	11.34	13.42	12.21	10.28	12.38	12.11	13.48	13.04	19.02	16.25	49.38	47.04	45.4
Total Debt/Total Assets (%)	- -	11.97	9.5	11.22	10.53	8.82	10.45	9.78	11.35	10.66	15.59	13.83	41.22	41.24	40.26
Net Debt to Equity	- -	-5.23	-8.51	-8.56	-8.45	-10.52	-5.52	-9.91	-6.21	-10.29	-11.08	-15.17	69.71	61.49	55.81
Net Debt/Capital (%)	- -	-5.52	-9.31	-9.36	-9.23	-11.75	-5.85	-11.01	-6.31	-10.91	-11.65	-16.88	39.84	36.57	34.54
EBITDA	-22	39	31	-4	6	30	12	8	21	36	96	136	239	263	204
EBITDA-CapEx	-32	14	13	-24	-10	9	-23	-39	-20	2	69	112	201	222	166
Operating Income (Loss)	-33	27	18	-18	-7	15	-4	-9	- -	11	70	107	197	205	140

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	- -	0.84	0.82	1.08	1.1	1.2	1.02	0.83	0.95	0.94	1.32	1.85	1.14	1.28	1.79
Current Ratio	- -	2.76	2.64	3.16	2.93	3.04	2.79	2.06	2.84	2.49	3.06	3.99	2.17	3.07	4.02
Quick Ratio	- -	1.47	1.23	1.45	1.66	1.64	1.64	1.32	1.46	1.53	2.08	2.79	1.65	2.07	2.8
CFO/Avg Current Liab	- -	-0.05	0.49	0.33	0.17	0.64	0.61	0.44	0.42	0.57	0.91	0.9	1.15	1.07	0.94
Common Equity/Total Assets	- -	73.53	74.26	72.39	75.75	76.98	73.99	64.73	64.97	63.73	66.34	71.25	42.26	46.42	48.41
Long-Term Debt/Equity (%)	- -	6.83	4	12.81	10.21	9.83	12.24	8.78	13.03	11.51	22.33	18.26	96.85	87.88	81.95
Long-Term Debt/Capital (%)	- -	5.88	3.55	11.09	8.96	8.82	10.72	7.71	11.27	10.01	18.08	15.29	49.03	46.54	44.74
Long-Term Debt/Total Assets (%)	- -	5.02	2.97	9.27	7.73	7.56	9.05	6.23	9.49	8.18	14.81	13.01	40.93	40.79	39.68
Total Debt/Equity (%)	- -	16.28	12.79	15.5	13.91	11.46	14.13	13.78	15.58	14.99	23.49	19.4	97.53	88.84	83.16
Total Debt/Capital (%)	- -	14	11.34	13.42	12.21	10.28	12.38	12.11	13.48	13.04	19.02	16.25	49.38	47.04	45.4
Total Debt/Total Assets (%)	- -	11.97	9.5	11.22	10.53	8.82	10.45	9.78	11.35	10.66	15.59	13.83	41.22	41.24	40.26
CFO/Total Liabilities	- -	-1.96	35.6	19.58	11.29	39.15	33.42	25.6	26.19	31.38	43.36	41.8	21.01	25.25	18.57
CFO/CapEx	1.92	-0.07	1.76	1.03	0.67	1.8	1.12	0.82	1	1.69	3.57	3.71	4.81	5.2	4.2
Altman's Z-Score	- -	1.85	1.74	4.05	5.37	6.66	5.75	4.79	4.63	4.41	4.81	6.03	4.47	3.93	3.4

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	11.22	7.53	8.87	8.97	8.5	7.65	6.68	6.61	6.28	6.05	5.95	6.33	5.83	5.14
Days Sales Outstanding	- -	32.52	48.46	41.13	40.69	42.92	47.7	54.6	55.22	58.1	60.37	61.3	57.7	62.64	70.95
Inventory Turnover	- -	4.44	2.35	2.09	2.28	2.01	2.09	2.82	2.12	1.99	2.51	2.55	2.8	2.76	2.2
Days Inventory Outstanding	- -	82.24	155.1	174.53	160.31	181.84	174.81	129.26	172.33	183.23	145.4	143.29	130.32	132.28	165.85
Accounts Payable Turnover	- -	18.73	8.48	11.24	13.52	9.47	7.3	8.07	8.22	7.8	10.05	12.22	12.87	14.51	12.26
Accounts Payable Turnover Days	- -	19.49	43.05	32.48	26.99	38.54	49.97	45.25	44.43	46.77	36.32	29.88	28.37	25.15	29.76
Cash Conversion Cycle	- -	95.27	160.51	183.18	174.02	186.21	172.54	138.61	183.12	194.56	169.45	174.71	159.65	169.77	207.03
Inventory to Cash Days	- -	-49.72	-106.63	-133.39	-119.62	-138.91	-127.12	-74.66	-117.11	-125.13	-85.03	-81.99	-72.61	-69.64	-94.9
Inventories	- -	51	70	82	71	80	64	69	111	97	93	104	106	154	177
Raw Materials	- -	29	34	42	30	36	20	30	59	47	42	48	50	82	107
Work In Process	- -	9	15	16	26	22	22	30	36	37	33	37	31	33	40
Finished Goods	- -	19	27	25	15	21	21	9	16	13	18	19	25	39	30
Other Inventory	- -	- -	- -	- -	3	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	518	643	852	897	928	898	955	1,111	1,348	2,973	1,768	1,222
- Cash & Cash Equivalents	- -	50	54	68	66	72	66	86	74	93	126	156	144	152	170
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	32	46	46	- -	- -	- -	- -	- -
+ Total Debt	- -	38	32	44	41	38	47	50	67	67	105	103	624	651	656
Enterprise Value	- -	-12	-21	494	618	817	876	921	926	963	1,079	1,275	3,340	2,197	1,596
Total Capital	- -	271	284	326	337	367	381	415	494	516	550	631	1,263	1,383	1,445
Total Debt/Capital (%)	- -	14	11.34	13.42	12.21	10.28	12.38	12.11	13.48	13.04	19.02	16.25	49.38	47.04	45.4
Total Debt / EV	- -	-3.11	-1.5	0.09	0.07	0.05	0.05	0.05	0.07	0.07	0.1	0.08	0.19	0.3	0.41
EV/Sales	- -	- -	- -	2.35	2.46	3.2	3.65	3.13	2.87	2.75	2.47	2.56	5.18	3	2.22
EV/EBITDA	- -	- -	- -	- -	97.29	27.18	73.62	116.68	43.92	26.66	11.19	9.39	13.99	8.37	7.84
EV/EBIT	- -	- -	- -	- -	- -	53.12	- -	- -	- -	87.93	15.44	11.86	16.95	10.69	11.36
EV/Cash Flow to Firm	- -	- -	- -	23.08	56.48	20.81	21.05	24.01	22.12	16.79	10.94	14.06	16.24	9.19	9.05
EV/Free Cash Flow to Firm	- -	- -	- -	11.79	22.95	13.47	11.42	10.81	11.1	10.56	8.56	11.12	13.7	7.85	7.47
Diluted Market Cap	- -	- -	- -	487	640	875	931	923	963	988	1,159	1,469	3,278	1,933	1,291
Diluted Enterprise Value	- -	-12	-21	463	615	840	912	919	1,002	1,009	1,138	1,415	3,757	2,432	1,777
EV per Share	- -	- -	- -	11.07	13.68	17.66	18.79	19.75	19.88	20.28	22.62	26.5	69.48	46.14	34.96
TTM Sales	118	204	230	210	252	255	240	295	322	350	438	499	644	732	720
TTM EBITDA	-22	39	31	-4	6	30	12	8	21	36	96	136	239	263	204
TTM Operating Income	-33	27	18	-18	-7	15	-4	-9	- -	11	70	107	197	205	140
TTM Cash Flow to Firm	19	-1	32	21	11	39	42	38	42	57	99	91	206	239	176
TTM Free Cash Flow to Firm	29	24	49	42	27	61	77	85	83	91	126	115	244	280	213

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	11.72	23.98	14.6	12.52	10.86	11.55	10.84	9.24	12.98	14.79	7.6	6.68
EV/EBIT	- -	- -	- -	- -	- -	53.12	- -	- -	- -	87.93	15.44	11.86	16.95	10.69	11.36
Enterprise Value	- -	-12	-21	494	618	817	876	921	926	963	1,079	1,275	3,340	2,197	1,596
Low Price	- -	- -	- -	6.67	10.57	10.5	12.05	14.4	16.71	12.32	16.91	22.07	27.58	36.48	20.39
EV/Sales	- -	- -	- -	2.35	2.46	3.2	3.65	3.13	2.87	2.75	2.47	2.56	5.18	3	2.22
EV/EBITDA	- -	- -	- -	- -	97.29	27.18	73.62	116.68	43.92	26.66	11.19	9.39	13.99	8.37	7.84
Price/Earnings	- -	- -	- -	- -	- -	85.11	243.24	- -	18.52	674.22	17.91	14.89	21.7	11.27	12.76
Price/Earnings Average	- -	- -	- -	-41.68	-230.62	73.52	210.88	-149.14	19.98	631.65	14.91	16.7	16.18	13.85	12.88
Price/Earnings High	- -	- -	- -	-49.11	-295.22	100.5	252.22	-183.87	24.41	760.72	18.34	23.62	23.74	20.01	18.59
Price/Earnings Low	- -	- -	- -	-26.16	-170.52	48.52	152.34	-116.43	16.04	413.22	13.01	11.73	9.68	11.08	9.72
Price/Book Value	- -	- -	- -	1.84	2.18	2.59	2.69	2.79	2.36	2.37	2.49	2.55	4.65	2.41	1.55
Price/Book Value Average	- -	- -	- -	1.68	2.19	2.23	2.33	2.59	2.54	2.22	2.08	2.86	3.47	2.97	1.56
Price/Book Value High	- -	- -	- -	1.98	2.8	3.06	2.79	3.19	3.11	2.68	2.55	4.05	5.09	4.29	2.26
Price/Book Value Low	- -	- -	- -	1.06	1.62	1.47	1.68	2.02	2.04	1.46	1.81	2.01	2.07	2.37	1.18
Price/Tangible Book Value	- -	- -	- -	2.17	2.52	3.05	3.11	3.2	2.64	2.64	2.73	2.74	113.8	12.48	5.49
Price/Tangible Book Value Average	- -	- -	- -	1.98	2.53	2.64	2.69	2.96	2.85	2.47	2.27	3.08	84.84	15.34	5.54
Price/Tangible Book Value High	- -	- -	- -	2.34	3.24	3.61	3.22	3.65	3.48	2.98	2.8	4.35	124.49	22.16	7.99
Price/Tangible Book Value Low	- -	- -	- -	1.24	1.87	1.74	1.95	2.31	2.29	1.62	1.98	2.16	50.74	12.26	4.18
Price/Sales	- -	- -	- -	2.31	2.54	3.28	3.69	3.13	2.81	2.7	2.54	2.73	4.63	2.46	1.74
Price/Sales Average	- -	- -	- -	2.12	2.56	2.83	3.2	2.9	3.03	2.53	2.11	3.06	3.45	3.02	1.75
Price/Sales High	- -	- -	- -	2.5	3.27	3.87	3.83	3.58	3.71	3.05	2.6	4.33	5.07	4.36	2.53
Price/Sales Low	- -	- -	- -	1.33	1.89	1.87	2.31	2.27	2.44	1.66	1.85	2.15	2.07	2.41	1.32
Price/Cash Flow	- -	- -	- -	23.14	59.9	21.68	22.62	24.17	21.7	16.52	11.36	15.25	16.27	8.43	8.02
Price/Cash Flow Average	- -	- -	- -	21.18	60.18	18.72	19.61	22.41	23.41	15.48	9.45	17.11	12.13	10.35	8.09
Price/Cash Flow High	- -	- -	- -	24.96	77.03	25.59	23.46	27.62	28.61	18.64	11.63	24.2	17.8	14.96	11.68
Price/Cash Flow Low	- -	- -	- -	13.29	44.49	12.36	14.17	17.49	18.8	10.12	8.24	12.02	7.25	8.28	6.11
Price/Free Cash Flow Average	- -	- -	- -	10.73	24.09	12.61	10.86	10.07	12.47	10.16	7.69	14.56	11.02	9.33	6.74
Price/Free Cash Flow High	- -	- -	- -	12.64	30.84	17.24	12.99	12.41	15.23	12.23	9.46	20.59	16.18	13.49	9.73
Price/Free Cash Flow Low	- -	- -	- -	6.74	17.81	8.32	7.84	7.86	10.01	6.64	6.71	10.22	6.59	7.46	5.09
EV/Sales Average	- -	- -	- -	2.14	2.47	2.75	3.16	2.9	3.13	2.62	2.06	2.92	4.18	3.65	2.39
EV/Sales High	- -	- -	- -	2.54	3.19	3.81	3.8	3.58	3.8	3.14	2.55	4.18	5.79	4.97	3.15
EV/Sales Low	- -	- -	- -	1.3	1.8	1.77	2.26	2.26	2.54	1.73	1.79	2.02	2.8	3.05	1.97
EV/EBITDA Average	- -	-0.31	-0.7	-127.41	97.76	23.33	63.81	108.44	47.83	25.35	9.36	10.74	11.29	10.17	8.44
EV/EBITDA High	- -	-0.31	-0.7	-151.33	126.24	32.32	76.63	133.81	58.04	30.41	11.58	15.36	15.63	13.85	11.13
EV/EBITDA Low	- -	-0.31	-0.7	-77.42	71.26	15.01	45.67	84.54	38.77	16.78	8.14	7.43	7.56	8.51	6.96
EV/EBIT Average	- -	-0.44	-1.22	-25.05	-90.05	45.6	-194.08	-99.26	-25,856.29	83.61	12.92	13.57	13.68	13	12.25
EV/EBIT High	- -	-0.44	-1.22	-29.75	-116.29	63.17	-233.05	-122.49	-31,373.19	100.3	15.97	19.4	18.94	17.71	16.14
EV/EBIT Low	- -	-0.44	-1.22	-15.22	-65.64	29.33	-138.9	-77.38	-20,959.05	55.36	11.23	9.38	9.16	10.89	10.09
Last Price	- -	- -	- -	11.61	14.23	18.42	19.24	19.9	19.29	20.11	23.29	28.02	61.85	37.13	26.78
High Price	- -	- -	- -	12.52	18.3	21.75	19.95	22.74	25.43	22.69	23.85	44.46	67.66	65.92	39.01
Enterprise Value Average	- -	-12	-21	450	621	701	759	856	1,008	916	903	1,459	2,696	2,671	1,719
Enterprise Value High	- -	-12	-21	535	802	971	912	1,056	1,224	1,099	1,116	2,086	3,732	3,638	2,266
Enterprise Value Low	- -	-12	-21	274	453	451	543	667	817	606	785	1,008	1,805	2,236	1,417

Shares Outstanding	- -	43	45	45	45	46	47	47	47	47	48	48	48	48	46
Diluted Weighted Avg Shares	8	8	8	42	45	48	48	46	50	49	50	52	53	52	48
Basic Weighted Avg Shares	8	8	8	42	45	45	46	46	47	47	48	49	48	48	47
Revenue per Share	14.79	25.54	28.71	5.02	5.59	5.62	5.21	6.35	6.86	7.44	9.16	10.28	13.35	15.11	15.4
EBITDA per Share	-2.79	4.87	3.84	-0.08	0.14	0.66	0.26	0.17	0.45	0.77	2.02	2.8	4.95	5.42	4.36
Operating Income per Share	-4.18	3.44	2.2	-0.43	-0.15	0.34	-0.08	-0.19	- -	0.23	1.46	2.21	4.08	4.24	3
Basic EPS, GAAP	0.97	2.26	1.48	-0.25	-0.06	0.22	0.08	-0.12	1.04	0.03	1.3	1.88	2.85	3.29	2.1
Basic EPS from Cont Ops	0.97	2.26	1.48	-0.25	-0.06	0.22	0.08	-0.14	0.99	0.02	1.32	1.88	2.85	3.29	2.1
Diluted EPS, GAAP	0.97	2.26	1.48	-0.25	-0.06	0.21	0.08	-0.12	0.98	0.03	1.25	1.74	2.6	3.06	2.03
Diluted EPS from Cont Ops	0.97	2.26	1.48	-0.25	-0.06	0.21	0.08	-0.14	0.93	0.02	1.27	1.74	2.6	3.06	2.03
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	2.39	-0.21	3.88	0.5	0.24	0.85	0.85	0.82	0.89	1.22	2.05	1.84	3.8	4.41	3.34
Free Cash Flow per Basic Share	1.14	-3.29	1.68	0.01	-0.12	0.38	0.09	-0.19	- -	0.5	1.48	1.34	3.01	3.56	2.55
Cash & Equivalents per Share	- -	1.16	1.2	1.52	1.46	1.58	1.46	1.91	1.83	2.22	2.86	3.65	5.34	4.65	6.2
Book Value per Share	- -	5.38	5.64	6.31	6.54	7.12	7.16	7.13	8.19	8.47	9.34	10.99	13.3	15.38	17.28
Tangible Book Value per Share	- -	4.4	4.74	5.36	5.66	6.03	6.19	6.22	7.3	7.62	8.52	10.21	0.54	2.97	4.88

Amphastar Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)